Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation

BACKGROUND: Epithelial-mesenchymal transition (EMT) played an important role in the progression of hepatocellular carcinoma (HCC) after insufficient radiofrequency ablation (RFA). However, whether sorafenib could be used to suppress the EMT of HCC after insufficient RFA and further prevent the progr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Dong, Shuying, Kong, Jian, Kong, Fandong, Kong, Jinge, Gao, Jun, Ji, Liang, Pan, Bing, Chen, Lian, Zheng, Lemin, Sun, Wenbing
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4663721/
https://ncbi.nlm.nih.gov/pubmed/26620566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1949-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados